We’re improving your shopping experience and some features may be unavailable from Saturday at 12 p.m. until Sunday at 4 a.m.  Thank you for your patience!

Physicians/Specialists
Facilities/Hospitals
Pharmacy
Publication Date: 
2022-07-01

Please note, this communication applies to Healthy Blue + MedicareSM (HMO D-SNP) offered by Blue Cross and Blue Shield of North Carolina.

Effective September 1, 2022, Vabysmo will be included in our medical step therapy precertification review process for ING-CC-0072. Step therapy review will apply upon precertification initiation, in addition to the current medical necessity review (as is current procedure). Step therapy will not apply for members who are actively receiving medications listed below.

Clinical UM Guidelines are publicly available on the provider website. Visit the Clinical Criteria page to search for specific criteria.

Clinical UM Guidelines Preferred drug(s) Nonpreferred drug(s)
ING-CC-0072 Avastin
Eylea
Lucentis
Byooviz
Macugen
Beovu
Vabysmo